We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.46B
AUM Growth
-$25.5M
Cap. Flow
-$13.6M
Cap. Flow %
-0.93%
Top 10 Hldgs %
23.16%
Holding
4,911
New
1,154
Increased
1,500
Reduced
1,460
Closed
679

Sector Composition

Rank Sector Weight
1 Technology 9.13%
2 Financials 8.46%
3 Industrials 5.89%
4 Healthcare 5.51%
5 Consumer Discretionary 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NNC
3376
DELISTED
Nuveen North Carolina Quality Municipal Income Fund
NNC
$5K ﹤0.01%
367
-629
-63% -$8.53K
IHTA
3377
DELISTED
Invesco High Income 2024 Target Term Fund
IHTA
$5K ﹤0.01%
+506
New +$5.22K
ERUS
3378
DELISTED
iShares MSCI Russia ETF
ERUS
$5K ﹤0.01%
+116
New +$4.49K
WBK
3379
DELISTED
Westpac Banking Corporation
WBK
$5K ﹤0.01%
+267
New +$5.23K
GCI
3380
DELISTED
Gannett Co., Inc
GCI
$5K ﹤0.01%
452
-428
-49% -$4.25K
ACET icon
3381
Adicet Bio
ACET
$74.7M
$4K ﹤0.01%
+4
New +$4.47K
ANIX icon
3382
Anixa Biosciences
ANIX
$116M
$4K ﹤0.01%
907
+698
+334% +$2.92K
AROW icon
3383
Arrow Financial
AROW
$652M
$4K ﹤0.01%
+131
New +$3.78K
ASRT
3384
DELISTED
Assertio
ASRT
$4K ﹤0.01%
53
+11
+26% +$1.43K
ATLO icon
3385
AMES National
ATLO
$277M
$4K ﹤0.01%
140
+110
+367% +$2.98K
ATRC icon
3386
AtriCure
ATRC
$2.11B
$4K ﹤0.01%
149
-554
-79% -$15.8K
BCSF icon
3387
Bain Capital Specialty
BCSF
$850M
$4K ﹤0.01%
+204
New +$3.68K
BLOK icon
3388
Amplify Blockchain Technology ETF
BLOK
$1.07B
$4K ﹤0.01%
200
BME icon
3389
BlackRock Health Sciences Trust
BME
$570M
$4K ﹤0.01%
100
-82
-45% -$3.16K
BPMC
3390
DELISTED
Blueprint Medicines
BPMC
$4K ﹤0.01%
55
+28
+104% +$2.42K
BTG icon
3391
B2Gold
BTG
$6.64B
$4K ﹤0.01%
1,090
-6,962
-86% -$23.4K
CARM
3392
DELISTED
Carisma Therapeutics
CARM
$4K ﹤0.01%
173
-29
-14% -$679
CEVA icon
3393
CEVA Inc
CEVA
$1.08B
$4K ﹤0.01%
+124
New +$3.61K
CHT icon
3394
Chunghwa Telecom
CHT
$33B
$4K ﹤0.01%
108
-2,775
-96% -$97.5K
CMRE icon
3395
Costamare
CMRE
$1.77B
$4K ﹤0.01%
738
-354
-32% -$2.04K
COLL icon
3396
Collegium Pharmaceutical
COLL
$956M
$4K ﹤0.01%
337
-734
-69% -$8.38K
CPF icon
3397
Central Pacific Financial
CPF
$1B
$4K ﹤0.01%
+152
New +$4.38K
CUE icon
3398
Cue Biopharma
CUE
$114M
$4K ﹤0.01%
+17
New +$4.08K
CVLG icon
3399
Covenant Logistics
CVLG
$872M
$4K ﹤0.01%
494
+178
+56% +$1.37K
CYH icon
3400
Community Health Systems
CYH
$423M
$4K ﹤0.01%
1,101
-1,376
-56% -$3.58K

Similar funds

Tower Research Capital (TRC)'s Q3 2019 Portfolio in Review

As of Q3 2019, Tower Research Capital (TRC) held 4,911 positions worth $1.46B, down 1.7% from $1.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC)'s Q3 2019 filing shows 1,154 new, 1,500 increased, 1,460 reduced and 679 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $119M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 4.3% a quarter earlier, followed by Financials and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2019 buy was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M.
  • Tower Research Capital (TRC) added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2019, an estimated $45.9M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $119M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2019, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $1.46B portfolio in Q3 2019.
  • Tower Research Capital (TRC) opened 1,154 new positions and closed 679 in Q3 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 1.7% quarter-over-quarter to $1.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2019, filed 5 Nov 2019.